Drug Screening of Human GBM Spheroids in Brain Cancer Chip

Glioblastoma multiforme (GBM), an extremely invasive and high-grade (grade IV) glioma, is the most common and aggressive form of brain cancer. It has a poor prognosis, with a median overall survival of only 11 months in the general GBM population and 14.6 to 21 months in clinical trial participants...

Descripción completa

Detalles Bibliográficos
Autores principales: Akay, Metin, Hite, John, Avci, Naze Gul, Fan, Yantao, Akay, Yasemin, Lu, Guangrong, Zhu, Jay-Jiguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194126/
https://www.ncbi.nlm.nih.gov/pubmed/30337660
http://dx.doi.org/10.1038/s41598-018-33641-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194126/
https://www.ncbi.nlm.nih.gov/pubmed/30337660
http://dx.doi.org/10.1038/s41598-018-33641-2

Ejemplares similares